<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1480" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1480/" /><meta name="ncbi_pagename" content="Lowe Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Lowe Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Lowe Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/04/18" /><meta name="citation_author" content="Richard Alan Lewis" /><meta name="citation_author" content="Robert L Nussbaum" /><meta name="citation_author" content="Eileen D Brewer" /><meta name="citation_pmid" content="20301653" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1480/" /><meta name="citation_keywords" content="Oculocerebrorenal Syndrome" /><meta name="citation_keywords" content="Oculocerebrorenal Syndrome of Lowe" /><meta name="citation_keywords" content="Oculocerebrorenal Syndrome" /><meta name="citation_keywords" content="Oculocerebrorenal Syndrome of Lowe" /><meta name="citation_keywords" content="Inositol polyphosphate 5-phosphatase OCRL" /><meta name="citation_keywords" content="OCRL" /><meta name="citation_keywords" content="Lowe Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Lowe Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Richard Alan Lewis" /><meta name="DC.Contributor" content="Robert L Nussbaum" /><meta name="DC.Contributor" content="Eileen D Brewer" /><meta name="DC.Date" content="2019/04/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1480/" /><meta name="description" content="Lowe syndrome (oculocerebrorenal syndrome) is characterized by involvement of the eyes, central nervous system, and kidneys. Dense congenital cataracts are found in all affected boys and infantile glaucoma in approximately 50%. All boys have impaired vision; corrected acuity is rarely better than 20/100. Generalized hypotonia is noted at birth and is of central (brain) origin. Deep tendon reflexes are usually absent. Hypotonia may slowly improve with age, but normal motor tone and strength are never achieved. Motor milestones are delayed. Almost all affected males have some degree of intellectual disability; 10%-25% function in the low-normal or borderline range, approximately 25% in the mild-to-moderate range, and 50%-65% in the severe-to-profound range of intellectual disability. Affected males have varying degrees of proximal renal tubular dysfunction of the Fanconi type, including low molecular-weight (LMW) proteinuria, aminoaciduria, bicarbonate wasting and renal tubular acidosis, phosphaturia with hypophosphatemia and renal rickets, hypercalciuria, sodium and potassium wasting, and polyuria. The features of symptomatic Fanconi syndrome do not usually become manifest until after the first few months of life, except for LMW proteinuria. Glomerulosclerosis associated with chronic tubular injury usually results in slowly progressive chronic renal failure and end-stage renal disease between the second and fourth decades of life." /><meta name="og:title" content="Lowe Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Lowe syndrome (oculocerebrorenal syndrome) is characterized by involvement of the eyes, central nervous system, and kidneys. Dense congenital cataracts are found in all affected boys and infantile glaucoma in approximately 50%. All boys have impaired vision; corrected acuity is rarely better than 20/100. Generalized hypotonia is noted at birth and is of central (brain) origin. Deep tendon reflexes are usually absent. Hypotonia may slowly improve with age, but normal motor tone and strength are never achieved. Motor milestones are delayed. Almost all affected males have some degree of intellectual disability; 10%-25% function in the low-normal or borderline range, approximately 25% in the mild-to-moderate range, and 50%-65% in the severe-to-profound range of intellectual disability. Affected males have varying degrees of proximal renal tubular dysfunction of the Fanconi type, including low molecular-weight (LMW) proteinuria, aminoaciduria, bicarbonate wasting and renal tubular acidosis, phosphaturia with hypophosphatemia and renal rickets, hypercalciuria, sodium and potassium wasting, and polyuria. The features of symptomatic Fanconi syndrome do not usually become manifest until after the first few months of life, except for LMW proteinuria. Glomerulosclerosis associated with chronic tubular injury usually results in slowly progressive chronic renal failure and end-stage renal disease between the second and fourth decades of life." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1480/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/lowe/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1480/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AF2D1E040FC010000000001BC00AD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1480_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1480_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rws/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lds/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1480_"><span class="title" itemprop="name">Lowe Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Oculocerebrorenal Syndrome, Oculocerebrorenal Syndrome of Lowe</div><p class="contrib-group"><span itemprop="author">Richard Alan Lewis</span>, MD, MS, <span itemprop="author">Robert L Nussbaum</span>, MD, and <span itemprop="author">Eileen D Brewer</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1480_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1480_ai__"><div class="contrib half_rhythm"><span itemprop="author">Richard Alan Lewis</span>, MD, MS<div class="affiliation small">Professor, Departments of Molecular and Human Genetics, Ophthalmology, Medicine, and Pediatrics<br />Baylor College of Medicine<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@siwelr" class="oemail">ude.mcb@siwelr</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert L Nussbaum</span>, MD<div class="affiliation small">Chief Medical Officer, Invitae Corporation<br />San Francisco, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.eativni@muabssun.trebor" class="oemail">moc.eativni@muabssun.trebor</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Eileen D Brewer</span>, MD<div class="affiliation small">Professor, Pediatric Renal Section<br />Baylor College of Medicine<br />Medical Director, Renal Transplantation<br />Texas Children's Hospital<br />Houston, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mcb@rewerbe" class="oemail">ude.mcb@rewerbe</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">July 24, 2001</span>; Last Update: <span itemprop="dateModified">April 18, 2019</span>.</p><p><em>Estimated reading time: 29 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="lowe.Summary" itemprop="description"><h2 id="_lowe_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Lowe syndrome (oculocerebrorenal syndrome) is characterized by involvement of the eyes, central nervous system, and kidneys. Dense <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts are found in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys and infantile glaucoma in approximately 50%. All boys have impaired vision; corrected acuity is rarely better than 20/100. Generalized hypotonia is noted at birth and is of central (brain) origin. Deep tendon reflexes are usually absent. Hypotonia may slowly improve with age, but normal motor tone and strength are never achieved. Motor milestones are delayed. Almost all affected males have some degree of intellectual disability; 10%-25% function in the low-normal or borderline range, approximately 25% in the mild-to-moderate range, and 50%-65% in the severe-to-profound range of intellectual disability. Affected males have varying degrees of proximal renal tubular dysfunction of the Fanconi type, including low molecular-weight (LMW) proteinuria, aminoaciduria, bicarbonate wasting and renal tubular acidosis, phosphaturia with hypophosphatemia and renal rickets, hypercalciuria, sodium and potassium wasting, and polyuria. The features of symptomatic Fanconi syndrome do not usually become manifest until after the first few months of life, except for LMW proteinuria. Glomerulosclerosis associated with chronic tubular injury usually results in slowly progressive chronic renal failure and end-stage renal disease between the second and fourth decades of life.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Lowe syndrome is established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical and laboratory findings and a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>OCRL</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The diagnosis of Lowe syndrome is rare in females but can be established in a female proband who demonstrates the same clinical and laboratory findings as a male proband and who is found to have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variant in <i>OCRL</i> by molecular genetic testing.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><ul><li class="half_rhythm"><div>Early removal of cataracts with postoperative glasses; management of glaucoma; early infant therapy, preschool intervention program and individualized education program throughout schooling; behavior modification plan; anticonvulsant therapy if seizures are present.</div></li><li class="half_rhythm"><div>Treatment of renal tubular dysfunction includes oral supplements of sodium and potassium bicarbonate or citrate to correct acidosis and hypokalemia, and oral phosphate and oral calcitriol (1,25-dihydroxyvitamin D<sub>3</sub>) to correct hypophosphatemia and renal rickets; treatment of ESRD with chronic dialysis and renal transplant in selected individuals.</div></li><li class="half_rhythm"><div>Consider human growth hormone therapy to improve growth velocity; tube feedings may be needed to treat infant feeding problems associated with hypotonia; standard treatment for gastroesophageal reflux if present. Bracing or surgery for severe or progressive scoliosis or joint hypermobility; resection of fibromas and cutaneous cysts if painful or impairing function.</div></li></ul><p><i>Surveillance:</i> Intraocular pressure monitoring every six months for life, other eye evaluations at intervals determined by specialist; at least annual assessment of kidney function, growth, developmental progress; annual evaluation for scoliosis and joint problems; semiannual dental examinations.</p><p><i>Circumstances to avoid:</i> Corneal contact lenses because of associated risk of corneal keloid formation and complexities of contact lens care; artificial lens implants because of probable increased risk of glaucoma.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Lowe syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. <i>De novo</i> pathogenic variants have been reported in 32% of males <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with Lowe syndrome. A high risk of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (4.5%) has been identified. When a mother is a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, each pregnancy has a 25% chance of an affected son, a 25% chance of a heterozygous daughter, a 25% chance of an unaffected son, and a 25% chance of a daughter who is not heterozygous. No affected male is known to have reproduced. Approximately 95% of heterozygous females older than age 15 years have characteristic findings in the lens of the eye on slit lamp examination by an experienced ophthalmologist using both direct and retroillumination. Once the <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an affected family member, molecular genetic prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="lowe.Diagnosis"><h2 id="_lowe_Diagnosis_">Diagnosis</h2><div id="lowe.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Lowe syndrome <b>should be suspected</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a combination of the following features:</p><ul><li class="half_rhythm"><div>Bilateral dense <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts</div></li><li class="half_rhythm"><div>Infantile <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypotonia</div></li><li class="half_rhythm"><div>Delayed development</div></li><li class="half_rhythm"><div>Proximal renal tubular transport dysfunction of the Fanconi type characterized by low molecular-weight (LMW) proteinuria (including retinol binding protein, N-acetyl glucosaminidase, and albumin), aminoaciduria and varying degrees of bicarbonaturia and acidosis, phosphaturia and hypophosphatemia, and hypercalciuria.</div></li></ul><p>Note: LMW proteinuria, characterized by the excretion of proteins such as retinal binding protein and N-acetyl glucosaminidase, is seen in Lowe syndrome, the allelic disorder Dent disease (see <a href="#lowe.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>), and many other diseases associated with the Fanconi syndrome. In Lowe syndrome, LMW proteinuria can be seen early in life even in the absence of clinically significant aminoaciduria or other renal tubular abnormalities [<a class="bk_pop" href="#lowe.REF.laube.2004.479">Laube et al 2004</a>]. Thus, LMW may be the most sensitive early marker of the renal dysfunction occurring in this disorder.</p></div><div id="lowe.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of Lowe syndrome <b>is established</b> in a male proband with typical clinical and laboratory findings and a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>OCRL</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1480/table/lowe.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figloweTmoleculargenetictestingusedin" rid-ob="figobloweTmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: If a variant of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a> or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in a male with a clinical diagnosis consistent with Lowe syndrome, testing of inositol polyphosphate 5-phosphatase OCRL-1 activity in cultured skin fibroblasts is a possible option. Affected males have less than 10% normal activity of the enzyme. Such testing is abnormal in more than 99% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and was shown to have high negative predictive value for Lowe syndrome in individuals referred with only partial overlap with Lowe syndrome <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> who had no pathogenic variant found in <i>OCRL</i> [<a class="bk_pop" href="#lowe.REF.hichri.2011.379">Hichri et al 2011</a>].</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of Lowe syndrome in females is rare but <b>can be established</b> in a female proband with the same clinical and laboratory findings as a male proband and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>OCRL</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. If a diagnosis of Lowe syndrome is established in a female, it is recommended that the clinician search for two pathogenic variants (one on each X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a>) or an X-autosome <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> or other biologic cause for highly skewed inactivation of the X chromosome carrying the normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in a female <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> [<a class="bk_pop" href="#lowe.REF.mueller.1991.804">Mueller et al 1991</a>, <a class="bk_pop" href="#lowe.REF.cau.2006.1030">Cau et al 2006</a>].</p><div id="lowe.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Lowe syndrome is broad, individuals with the distinctive findings described in <a href="#lowe.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <b>Option 1</b>), whereas those with atypical features or in whom the diagnosis of Lowe syndrome has not been considered are more likely to be diagnosed using genomic testing (see <b>Option 2</b>).</p><p><b>Option 1.</b> When the phenotypic and laboratory findings suggest the diagnosis of Lowe syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>OCRL</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Note: Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>OCRL</i> and other genes of interest (see <a href="#lowe.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK1480/table/lowe.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figloweTmoleculargenetictestingusedin" rid-ob="figobloweTmoleculargenetictestingusedin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><p><b>Option 2.</b> When the diagnosis of Lowe syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="lowe.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Lowe Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>OCRL</i></td><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~95%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype</td><td headers="hd_h_lowe.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lowe.TF.1.1"><p class="no_margin">See <a href="/books/NBK1480/#lowe.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="lowe.TF.1.2"><p class="no_margin">See <a href="#lowe.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="lowe.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="lowe.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="lowe.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#lowe.REF.monnier.2000.157">Monnier et al [2000]</a>, <a class="bk_pop" href="#lowe.REF.hichri.2011.379">Hichri et al [2011]</a>, <a class="bk_pop" href="#lowe.REF.recker.2015.931">Recker et al [2015]</a></p></div></dd><dt>6. </dt><dd><div id="lowe.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="lowe.TF.1.7"><p class="no_margin">Translocations between an autosome and an X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> with a breakpoint through <i>OCRL</i> (Xq26.1) have been observed in females with Lowe syndrome [<a class="bk_pop" href="#lowe.REF.hodgson.1986.837">Hodgson et al 1986</a>, <a class="bk_pop" href="#lowe.REF.reilly.1988.748">Reilly et al 1988</a>, <a class="bk_pop" href="#lowe.REF.mueller.1991.804">Mueller et al 1991</a>]; therefore, in an individual with Lowe syndrome in whom a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been detected by other methods, <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> may be considered.</p></div></dd></dl></div></div></div></div></div></div><div id="lowe.Clinical_Characteristics"><h2 id="_lowe_Clinical_Characteristics_">Clinical Characteristics</h2><div id="lowe.Clinical_Description"><h3>Clinical Description</h3><p>Usually only males have the disorder. A few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females with the clinical manifestations of Lowe syndrome have been reported [<a class="bk_pop" href="#lowe.REF.cau.2006.1030">Cau et al 2006</a>].</p><p>The major clinical manifestations found in males with Lowe syndrome involve the eyes, central nervous system, and kidneys. Nearly all post-pubertal <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females have lens opacities; a few will have additional findings. With the wide availability of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, phenotypic heterogeneity appears to be substantially greater than previously suspected, such that individuals who lack certain features of Lowe syndrome can still have pathogenic variants in <i>OCRL</i>.</p><div id="lowe.Males"><h4>Males</h4><p><b>Eyes.</b> Dense <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts, formed as a result of abnormal metabolism or migration of the embryonic lens epithelium, are found in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys. Although present at birth, the cataracts may not be detected until a few weeks of life. Rarely, the lens opacities are so mild that they do not affect visual development, even into the teen years.</p><ul><li class="half_rhythm"><div>Microphthalmos and enophthalmos, related to the lens abnormality, are noted occasionally.</div></li><li class="half_rhythm"><div>Infantile glaucoma, present in approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males, is difficult to control and often results in buphthalmos (enlarged eyes) and progressive visual loss [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001_1">Nussbaum &#x00026; Suchy 2001</a>]. Often the glaucoma is not detected until after the lenses have been removed. The glaucoma is severe and requires surgical, rather than medical, management.</div></li><li class="half_rhythm"><div>Strabismus, retinal dystrophy, secondary corneal scarring, and calcific band keratopathy with keloid formation [<a class="bk_pop" href="#lowe.REF.cibis.1982.1795">Cibis et al 1982</a>] may cause additional visual impairment [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001_1">Nussbaum &#x00026; Suchy 2001</a>].</div></li></ul><p>All boys have impaired vision; corrected acuity is rarely better than 20/100 [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001_1">Nussbaum &#x00026; Suchy 2001</a>]. With decreased visual acuity, nystagmus develops early in life, even with early and uncomplicated surgery. Self-stimulatory activity also increases, i.e., rhythmic flapping of the hands, eye rubbing, and repetitive rocking movements. Despite aggressive intervention, visual disability may progress to blindness.</p><p><b>Central nervous system.</b> Generalized infantile hypotonia is noted soon after birth and is of central origin. Deep tendon reflexes are usually absent. Hypotonia may slowly improve with age, but neither normal motor tone nor strength is ever achieved.</p><ul><li class="half_rhythm"><div>Feeding difficulties in infancy associated with poor head control, sucking, or swallowing may be a consequence of the hypotonia.</div></li><li class="half_rhythm"><div>Decreased motor tone also results in delayed motor milestones. Independent ambulation occurs in approximately 25% of boys between age three and six years and in 75% by age six to 13 years. Some never walk, requiring the use of a wheelchair for mobility [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>].</div></li></ul><p>Approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys have seizure disorders, most often of the generalized type and usually starting before age six years [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>].</p><p>Behavior problems (i.e., self-stimulation or stereotypic and obsessive-compulsive behaviors) are frequent and include many problems common to visually and intellectually handicapped individuals. Occasionally, violent tantrums or aggressive and self-abusive behaviors occur [<a class="bk_pop" href="#lowe.REF.charnas.1991.75">Charnas &#x00026; Gahl 1991</a>, <a class="bk_pop" href="#lowe.REF.kenworthy.1993.297">Kenworthy et al 1993</a>].</p><p>Almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have some degree of intellectual impairment. Between 10% and 25% of affected males function in the low-normal or borderline range, approximately 25% function in the mild-to-moderate range, and 50%-65% function in the severe-to-profound range of intellectual disability [<a class="bk_pop" href="#lowe.REF.kenworthy.1993.297">Kenworthy et al 1993</a>]. Delayed language development is evident in early childhood. Most individuals learn to communicate verbally to some extent by age seven years; some eventually become quite verbal [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>]. Love of music and rhythm are notable.</p><p>As adults, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> men reside with their families. A few are functional enough to live in a group home or even independently with appropriate assistance and guidance.</p><p><b>Kidneys.</b> Affected boys have varying degrees of proximal renal tubular dysfunction of the renal Fanconi type. The features of symptomatic Fanconi syndrome do not usually become manifest until after the first few months of life, except for low molecular-weight (LMW) proteinuria.</p><ul><li class="half_rhythm"><div>LMW proteins are normally filtered by the glomerulus, then reabsorbed in the proximal tubule through endocytosis and metabolized in lysosomes in proximal tubular cells.</div></li><li class="half_rhythm"><div>When reabsorption and/or metabolism are dysfunctional, LMW proteins, including retinol-binding protein, beta-2-microglobulin, and the lysosmal enzyme N-acetyl glucosaminidase, are lost in the urine. LMW proteinuria has been identified as early as just after birth [<a class="bk_pop" href="#lowe.REF.laube.2004.479">Laube et al 2004</a>] and may be the most sensitive early marker for renal involvement of Lowe syndrome.</div></li></ul><p>The molecular size of albumin is at the upper end of the size range for LMW proteins, so the small percentage of albumin that is normally filtered by the glomerulus is also reabsorbed and metabolized by the proximal tubule via the LMW protein transport process.</p><p>In Lowe syndrome, proximal renal tubular dysfunction often leads to clinically apparent albuminuria (urine dipstick albumin 1-4+; nephrotic range proteinuria &#x0003e;1 g/m<sup>2</sup>/day in more than half), while serum albumin remains normal [<a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>]. Albuminuria is better known as a marker of glomerular injury in other diseases such as diabetes mellitus; in Lowe syndrome it likely reflects proximal tubular dysfunction, especially early in life before chronic renal failure occurs.</p><p>All boys have LMW proteinuria and albuminuria, likely due to downstream disordered endocytosis and postendocytic membrane trafficking in the proximal tubular cell [<a class="bk_pop" href="#lowe.REF.cui.2010.f335">Cui et al 2010</a>, <a class="bk_pop" href="#lowe.REF.de_matteis.2017.455">De Matteis et al 2017</a>]. Most boys have aminoaciduria [<a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>]. Some boys develop full-blown renal Fanconi syndrome with bicarbonaturia and renal tubular acidosis, phosphaturia with hypophosphatemia and renal rickets, sodium and potassium wasting, and polyuria with an apparent urine-concentrating defect from the massive solute loss in the urine. Few of these boys have renal glucose wasting, which is frequently observed in other diseases with full-spectrum renal Fanconi syndrome [<a class="bk_pop" href="#lowe.REF.bockenhauer.2008.1430">Bockenhauer et al 2008</a>, <a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>, <a class="bk_pop" href="#lowe.REF.zaniew.2018.85">Zaniew et al 2018</a>]. Other boys have little or no bicarbonaturia and phosphaturia, but LMW proteinuria and hypercalciuria with nephrocalcinosis and nephrolithiasis (calcium oxalate and calcium phosphate stones) similar to <a href="/books/n/gene/dent/">Dent disease</a> [<a class="bk_pop" href="#lowe.REF.bockenhauer.2008.1430">Bockenhauer et al 2008</a>, <a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>].</p><p>Progressive glomerulosclerosis likely results from progressive renal tubular injury, which eventually may lead to chronic kidney disease (CKD) and end-stage renal disease (ESRD) between the second and fourth decades of life [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001_1">Nussbaum &#x00026; Suchy 2001</a>, <a class="bk_pop" href="#lowe.REF.zaniew.2018.85">Zaniew et al 2018</a>].</p><p><b>Life span</b>. Most males do not live past age 40 years. In older individuals, death has been related to progressive renal failure or scoliosis. Death from dehydration, pneumonia, and infections occurs at all ages [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>].</p><p><b>Short stature.</b> Although birth length is usually normal, linear growth velocity is below normal and short stature becomes evident by age one year. The average adult height is approximately 155 cm [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>]. CKD and acidosis along with renal rickets or other bone disease may contribute to the short stature. Some boys have been treated with growth hormone, resulting in an increase in height but persistence of short stature for age [<a class="bk_pop" href="#lowe.REF.zaniew.2018.85">Zaniew et al 2018</a>].</p><p><b>Feeding and gastrointestinal concerns</b></p><ul><li class="half_rhythm"><div>Slow weight gain may occur because of insufficient caloric intake.</div></li><li class="half_rhythm"><div>Gastroesophageal reflux, most common in infancy, may be seen at any age.</div></li><li class="half_rhythm"><div>Aspiration of food along with a decreased ability to cough effectively to clear lung fields may lead to atelectasis, pneumonia, or chronic lung disease.</div></li><li class="half_rhythm"><div>Poor abdominal muscle tone increases the risk for chronic constipation and the development of (predominantly inguinal) hernias.</div></li></ul><p><b>Bone disease</b> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys may be related to Fanconi syndrome with phosphaturia, inadequate renal production of 1,25-dihydroxyvitamin D, and chronic acidosis as well as CKD. The bone disease may appear as classic changes of rickets on bone radiographs.</p><p>However, even in the presence of well-corrected Fanconi syndrome and no findings of rickets, some boys have repeat pathologic bone fractures with poor healing and bone demineralization on radiographs or bone densitometry [E Brewer, personal observation].</p><p>Whether some of the bone disease is related to inactivity resulting from muscle hypotonia and immobilization in severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys or to a primary defect in bone mineralization/molecular transport requires further study.</p><p><b>Other musculoskeletal concerns</b></p><ul><li class="half_rhythm"><div>Decreased truncal motor tone increases the risk of developing scoliosis, present in approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>].</div></li><li class="half_rhythm"><div>Hypermobile joints may result in joint dislocation, especially of the hips and knees.</div></li><li class="half_rhythm"><div>In <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> teenagers and adults, joint swelling, arthritis, tenosynovitis, and subcutaneous benign fibromas, often on the hands and feet and most especially in areas of repeated trauma, are noted frequently [<a class="bk_pop" href="#lowe.REF.athreya.1983.728">Athreya et al 1983</a>, <a class="bk_pop" href="#lowe.REF.elliman.1983.1011">Elliman &#x00026; Woodley 1983</a>].</div></li><li class="half_rhythm"><div>Elevated serum creatine kinase (CK), AST, and LDH are typical in Lowe syndrome and likely due to abnormal muscle metabolism [<a class="bk_pop" href="#lowe.REF.charnas.1991.1318">Charnas et al 1991</a>, <a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>]. Decreased plasma carnitine concentration has been reported in approximately one third of individuals with Lowe syndrome [<a class="bk_pop" href="#lowe.REF.charnas.1991.1318">Charnas et al 1991</a>], but the need for or efficacy of carnitine supplementation has never been studied, and therapy continues to be individualized.</div></li></ul><p><b>Genitourinary issues</b></p><ul><li class="half_rhythm"><div>Undescended testes (cryptorchidism) are noted in approximately one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> boys [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.recker.2015.931">Recker et al 2015</a>]. Isolated LH elevation at baseline and on GnRH stimulation testing was observed in an infant with undescended testes [<a class="bk_pop" href="#lowe.REF.warner.2017.2017">Warner et al 2017</a>].</div></li><li class="half_rhythm"><div>Puberty may be delayed in onset; otherwise, male secondary sexual development is normal.</div></li></ul><p><b>Teeth and skin findings.</b> Dental malformations and generalized mobility of primary teeth with decreased or dysplastic dentin formation may also be related to a primary dental abnormality in Lowe syndrome [<a class="bk_pop" href="#lowe.REF.harrison.1999.425">Harrison et al 1999</a>].</p><p>Superficial cysts may occur in the mouth and on the skin, especially the scalp, lower back and buttocks.The skin cysts may become painful and occasionally infected. Histologic examination revealed epidermal cysts in which the dermis was lined by several layers of stratified squamous epithelium with a granular layer and filled with keratin flakes [<a class="bk_pop" href="#lowe.REF.ikehara.2017.105">Ikehara &#x00026; Utani 2017</a>]. Cysts have also been found in imaging studies of the kidneys and brain. These findings suggest that an abnormality in connective tissue may also be involved in the pathogenesis of the disorder [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.kim.2014.140">Kim et al 2014</a>, <a class="bk_pop" href="#lowe.REF.murakami.2018.372">Murakami et al 2018</a>].</p><p><b>Coagulation disorder.</b> The OCRL-1 protein is found in human platelets. Prolonged or delayed bleeding following surgery, such as cataract extraction has been reported. An intrinsic platelet defect in these individuals that can be detected using a platelet function analyzer (PFA-100) was identified; other coagulation profile related tests, including platelet counts, gave normal results [<a class="bk_pop" href="#lowe.REF.lasne.2010.685">Lasne et al 2010</a>]. In another study, thrombocytopenia/low normal platelets were found in about 20% [<a class="bk_pop" href="#lowe.REF.recker.2015.931">Recker et al 2015</a>].</p></div><div id="lowe.Females"><h4>Females</h4><p>Approximately 95% of postpubertal <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females have characteristic findings in the lens of each eye on slit lamp examination through a dilated pupil by an experienced ophthalmologist. The lens findings have correlated with the results of molecular genetic studies in predicting heterozygosity for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>OCRL</i> in postpubertal females [<a class="bk_pop" href="#lowe.REF.lin.1999.119">Lin et al 1999</a>, <a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>, <a class="bk_pop" href="#lowe.REF.r_schinger.2000.213">R&#x000f6;schinger et al 2000</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001_1">Nussbaum &#x00026; Suchy 2001</a>]. While the lens findings may appear in prepubertal females as well (especially the less common axial posterior central opacity), their absence does not exclude the possibility of heterozygosity.</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females show numerous irregular, punctate, smooth, off-white (white to gray) opacities, present in the lens cortex, more in the anterior cortex than the posterior cortex, and distributed in radial bands that wrap around the lens equator. Classically, the nucleus is spared. On retroillumination, the opacities are distributed in a radial, spoke-like pattern and can be relatively dense in a wedge shape comparable to an hour or two on the face of a clock, alternating with a similar-sized wedge with few to no opacities.</p><p>A few <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females (~10%) have a dense central precapsular dead-white cataract at the posterior pole of the lens that may be visually significant if it is large. Similarly, the cataracts in some heterozygous females may become visually significant by the fourth decade and require surgery without the diagnostic importance being recognized.</p><p>The manifestations of Lowe syndrome besides those seen in the lens are not observed in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females unless there is either rare X;autosome <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> breakpoint at <i>OCRL</i> or extremely skewed X inactivation. In an example of the latter, a female with two structurally normal X chromosomes showed classic, severe Lowe syndrome as a result of a <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> defect in X inactivation inherited from her father. The paternally derived X chromosome containing a normal <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> remained inactive in 100% of cells, while the maternally derived X chromosome carrying a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of <i>ORCL</i> was active in 100% of cells tested [<a class="bk_pop" href="#lowe.REF.cau.2006.1030">Cau et al 2006</a>].</p></div></div><div id="lowe.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date, correlation of <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> with <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has not been established. Differing clinical courses have been noted in unrelated individuals with the same <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#lowe.REF.leahey.1993.461">Leahey et al 1993</a>]. It is also now apparent that pathogenic variants in <i>OCRL</i> that result in total loss of <i>OCRL</i> expression occur both in individuals with Lowe syndrome and in individuals with the allelic disorder, <a href="/books/n/gene/dent/">Dent disease</a>, but there have not been families in which one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male has Lowe syndrome and a male relative with the same pathogenic variant has Dent disease.</p></div><div id="lowe.Penetrance"><h3>Penetrance</h3><p>Penetrance is complete, with variability in severity of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males within any given family.</p></div><div id="lowe.Nomenclature"><h3>Nomenclature</h3><p>Oculocerebrorenal syndrome, the formal term for this disorder, is synonymous with Lowe syndrome, and may be preferred to avoid eponymous syndrome nomenclature.</p></div><div id="lowe.Prevalence"><h3>Prevalence</h3><p>Lowe syndrome is an uncommon, pan ethnic disorder with an estimated prevalence of 1:500,000 in the general population, based on observations of the American Lowe Syndrome Association and the Italian Association of Lowe syndrome [<a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>].</p><p>The disorder has been seen in America, Europe, Australia, Japan, and India and is believed to occur worldwide.</p></div></div><div id="lowe.Genetically_Related_Allelic_Disorde"><h2 id="_lowe_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>Pathogenic variants in <i>OCRL</i> have been found in 15% of individuals with <a href="/books/n/gene/dent/">Dent disease</a>. Pathogenic variants in <i>OCRL</i> can therefore occur within individuals with the <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> renal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Dent disease who lack the cataracts, renal tubular acidosis, and neurologic abnormalities that are characteristic of Lowe syndrome; these individuals are classified as having Dent disease 2 [<a class="bk_pop" href="#lowe.REF.hoopes.2005.260">Hoopes et al 2005</a>, <a class="bk_pop" href="#lowe.REF.b_kenkamp.2009.94">B&#x000f6;kenkamp et al 2009</a>, <a class="bk_pop" href="#lowe.REF.de_matteis.2017.455">De Matteis et al 2017</a>].</p><p>Although the renal tubulopathy in Lowe syndrome (which is mainly characterized by altered low molecular-weight protein and albumin reabsorption) and Dent disease is similar, it is generally milder in Dent disease. Of note, this milder Dent disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> could not be attributed to lesser protein expression or enzyme activity.</p><p>Frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <i>OCRL</i> variants associated with Dent disease 2 have been mapped to exons different from those causing Lowe syndrome [<a class="bk_pop" href="#lowe.REF.hichri.2011.379">Hichri et al 2011</a>]; however, <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants and <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> deletions that cause these two disorders do not map exclusively to specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> regions.</p><ul><li class="half_rhythm"><div>Frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants associated with Dent disease 2 are in the first seven exons. Missense variants associated with Dent disease 2 are most often, but not exclusively, located in exons 9-15, which encode the catalytic phosphatase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</div></li><li class="half_rhythm"><div>Frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants associated with Lowe syndrome are located in the middle and later regions of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, exons 8-23, which encode the catalytic phosphatase and the Rho-GAP-like domains [<a class="bk_pop" href="#lowe.REF.tosetto.2009.1967">Tosetto et al 2009</a>, <a class="bk_pop" href="#lowe.REF.hichri.2011.379">Hichri et al 2011</a>].</div></li></ul></div><div id="lowe.Differential_Diagnosis"><h2 id="_lowe_Differential_Diagnosis_">Differential Diagnosis</h2><p>Low molecular-weight (LMW) proteinuria is a feature of Fanconi syndrome and can also be seen in other conditions including <a href="/books/n/gene/ctns/">cystinosis</a>, nephrotoxic drug injury to the tubules (e.g., aminoglycosides), and acute tubulointerstitial renal transplant rejection with tubular injury. However, the LMW proteinuria appears to be a more prominent feature of renal tubular dysfunction in Lowe syndrome and Dent disease than in these other disorders.</p><p>Like Lowe syndrome, generalized <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> infections (e.g., rubella) are associated with a combination of congenital or neonatal-onset cataracts, hypotonia, proximal renal tubular dysfunction, and/or delayed development and should be considered in the differential diagnosis of Lowe syndrome. Genetic disorders that may be associated with these features are summarized in <a class="figpopup" href="/books/NBK1480/table/lowe.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object" rid-figpopup="figloweTdisorderstoconsiderinthediff" rid-ob="figobloweTdisorderstoconsiderinthediff">Table 2</a>.</p><div id="lowe.T.disorders_to_consider_in_the_diff" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Lowe Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.T.disorders_to_consider_in_the_diff/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.T.disorders_to_consider_in_the_diff_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder</th><th id="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Lowe syndrome</th><th headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4" id="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Lowe syndrome</th></tr></thead><tbody><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pbd/">Zellweger spectrum disorder</a></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX1</i><br /><i>PEX6</i><br /><i>PEX12</i><br /><i>PEX26</i><br /><i>PEX10</i><br /><i>PEX2</i><br /><i>PEX5</i><br /><i>PEX13</i><br /><i>PEX16</i><br /><i>PEX3</i><br /><i>PEX19</i><br /><i>PEX14</i><br /><i>PEX11&#x003b2;</i></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>May have <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts</div></li><li class="half_rhythm"><div>Retinal dystrophy</div></li><li class="half_rhythm"><div>Renal cysts</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Poor feeding</div></li><li class="half_rhythm"><div>Neonatal seizures common</div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Distinctive craniofacial features (e.g., flat face, broad nasal bridge, large anterior fontanelle, &#x00026; widely split sutures)</div></li><li class="half_rhythm"><div>SNHL</div></li><li class="half_rhythm"><div>Liver dysfunction</div></li><li class="half_rhythm"><div>Bony stippling (chondrodysplasia punctata) of patella(e) &#x00026; other long bones may occur.</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nance-Horan syndrome<br />(OMIM <a href="http://omim.org/entry/302350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">302350</a>)</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NHS</i></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital cataracts</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Dental anomalies (e.g., cone-shaped incisors &#x00026; supernumerary teeth)</div></li><li class="half_rhythm"><div>Heterozygous females have Y-shaped sutural cataracts &#x00026; may have dental anomalies.</div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Microcornea</div></li><li class="half_rhythm"><div>No renal abnormalities</div></li><li class="half_rhythm"><div>Facial dysmorphisms (e.g., anteverted pinnae)</div></li><li class="half_rhythm"><div>Absence of characteristic facial appearance seen in Lowe syndrome (i.e., sunken orbits &#x00026; bitemporal hollowing)</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/slo/">Smith-Lemli-Opitz syndrome</a></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DHCR7</i></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital cataracts</div></li><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Renal anomalies (most commonly renal hypoplasia or agenesis, renal cortical cysts, hydronephrosis, &#x00026; structural anomalies of collecting system)</div></li><li class="half_rhythm"><div>Moderate-to-severe ID</div></li><li class="half_rhythm"><div>Prenatal &#x00026; postnatal growth restriction</div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple major &#x00026; minor malformations including:
<ul><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Distinctive facial features</div></li><li class="half_rhythm"><div>Cleft palate</div></li><li class="half_rhythm"><div>Cardiac defects</div></li><li class="half_rhythm"><div>Underdeveloped external genitalia in males</div></li><li class="half_rhythm"><div>Postaxial polydactyly</div></li><li class="half_rhythm"><div>2-3 toe syndactyly</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/myotonic-d/">Congenital myotonic dystrophy type 1</a></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DMPK</i></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cataracts</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Infantile hypotonia; severe generalized weakness at birth</div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Respiratory insufficiency at birth</div></li><li class="half_rhythm"><div>No significant renal disease</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorders of mitochondrial oxidative phosphorylation&#x000a0;<sup>3</sup></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Hypotonia at birth or developing in early infancy</div></li><li class="half_rhythm"><div>Renal findings incl Fanconi syndrome, RTA, &#x00026; renal failure are frequent (especially in Kearns-Sayre syndrome, mt encephalomyopathy &#x00026; mt depletion syndrome)&#x000a0;<sup>3</sup></div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Common features of mt disease incl: ptosis, external ophthalmoplegia, proximal myopathy, exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, &#x00026; diabetes mellitus</div></li><li class="half_rhythm"><div>Central nervous system findings (often fluctuating): encephalopathy, dementia, migraine, stroke-like episodes, &#x00026; ataxia</div></li><li class="half_rhythm"><div>Note: Congenital cataract is seen in <i>GFER</i>-related mt myopathy (OMIM <a href="https://omim.org/entry/613076" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613076</a>) but is NOT typical for mt disorders</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ctns/">Cystinosis</a></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CTNS</i></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Renal Fanconi syndrome&#x000a0;<sup>2</sup>; CKD</div></li><li class="half_rhythm"><div>Poor growth; in untreated individuals, failure to grow is generally noticed at age 6-9 mos</div></li><li class="half_rhythm"><div>Retinal disease</div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typical cystine crystals on slit lamp examination of cornea</div></li><li class="half_rhythm"><div>No cataracts</div></li><li class="half_rhythm"><div>Intellectual abilities low-normal</div></li><li class="half_rhythm"><div>No hypotonia</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/books/NBK1878/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Donnai-Barrow syndrome</a></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LRP2</i></td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>LMW proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, CKD&#x000a0;<sup>4</sup></div></li><li class="half_rhythm"><div>Cataract may be seen in juveniles w/Donnai-Barrow syndrome</div></li></ul>
</td><td headers="hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_1_4 hd_h_lowe.T.disorders_to_consider_in_the_diff_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>High myopia</div></li><li class="half_rhythm"><div>No <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts</div></li><li class="half_rhythm"><div>SNHL</div></li><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Large anterior fontanelles</div></li><li class="half_rhythm"><div>Hypotonia not typical; motor milestones only slightly delayed</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CKD = chronic kidney disease; DD = developmental delay; ID = intellectual disability; LMW = low molecular-weight; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; mt = mitochondrial; RTA = renal tubular acidosis; SNHL = sensorineural hearing loss; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="lowe.TF.2.1"><p class="no_margin">Mitochondrial disorders may be caused by defects of nuclear DNA or mtDNA: nuclear <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defects may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner, mitochondrial DNA defects are transmitted by maternal inheritance.</p></div></dd><dt>2. </dt><dd><div id="lowe.TF.2.2"><p class="no_margin">Cystine-depleting therapy begun just after birth can attenuate the Fanconi syndrome.</p></div></dd><dt>3. </dt><dd><div id="lowe.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#lowe.REF.finsterer.2017.487">Finsterer &#x00026; Scorza [2017]</a></p></div></dd><dt>4. </dt><dd><div id="lowe.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#lowe.REF.anglani.2018.187">Anglani et al [2018]</a></p></div></dd></dl></div></div></div></div><div id="lowe.Management"><h2 id="_lowe_Management_">Management</h2><div id="lowe.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with Lowe syndrome, the evaluations summarized in <a class="figpopup" href="/books/NBK1480/table/lowe.T.recommended_evaluations_following/?report=objectonly" target="object" rid-figpopup="figloweTrecommendedevaluationsfollowing" rid-ob="figobloweTrecommendedevaluationsfollowing">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="lowe.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Lowe Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.T.recommended_evaluations_following_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/<br />Concern</th><th id="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic exam to assess for cataract &#x00026; glaucoma</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Behavior problems may necessitate use of anesthesia for exam.</td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>CNS</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Developmental &#x00026; behavior assessments</div></li><li class="half_rhythm"><div>EEG if seizures present to optimize therapy</div></li></ul>
</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Kidneys</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess renal tubular function.</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tests should include:
<ul><li class="half_rhythm"><div>Serum electrolytes, glucose, calcium, phosphorus &#x00026; creatinine</div></li><li class="half_rhythm"><div>Simultaneous urinalysis, urine pH, sodium, potassium, chloride, calcium, phosphorus, creatinine, amino acids, protein &#x00026; retinol-binding protein, &#x00026;/or N-acetyl glucosaminidase (if available)&#x000a0;<sup>1</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">If hematuria or hypercalciuria is present, renal ultrasound to look for nephrolithiasis or nephrocalcinosis.</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">If aciduria or phosphaturia present, test serum 1,25-dihydroxy vitamin D &#x00026; parathyroid hormone plus bone radiographs to evaluate for renal rickets.</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth/</b><br /><b>Feeding</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Growth parameters</div></li><li class="half_rhythm"><div>Infants assessed for feeding problems &#x00026; gastroesophageal reflux, incl a pH probe study</div></li></ul>
</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Radiographs for bone pain or point tenderness to evaluate for fractures</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thorough clinical exam after tooth eruption</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Generalized mobility of all primary teeth as well as subrachitic changes due to renal rickets</td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alert providers performing any surgical interventions of risk for delayed bleeding after apparent hemostasis in immediate post-op period.</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/a clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_lowe.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lowe.TF.3.1"><p class="no_margin">Interpretation of these results allows diagnosis of type 2 renal tubular acidosis, hypokalemia, phosphate wasting with decreased tubular reabsorption of phosphate (TRP), hypercalciuria (urine calcium/creatinine ratio &#x0003e;0.02), amino aciduria, albuminuria (urine dipstick-positive albumin and urine protein/creatinine ratio &#x0003e;0.2), LMW proteinuria, and CKD (serum creatinine).</p></div></dd></dl></div></div></div></div><div id="lowe.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of the varying clinical problems usually requires more than one medical specialist; experts in pediatric ophthalmology, nephrology, clinical biochemical genetics, metabolism, nutrition, endocrinology, neurology, child development, behavior, rehabilitation, general surgery, orthopedics, or dentistry may be involved.</p><div id="lowe.T.treatment_of_manifestations_in_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Lowe Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.T.treatment_of_manifestations_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.T.treatment_of_manifestations_in_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cataract</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early removal to promote proper visual stimulation &#x00026; development</div></li><li class="half_rhythm"><div>Postoperative glasses to improve vision &#x00026; replace the crystalline lens power</div></li></ul>
</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NOT recommended:
<ul><li class="half_rhythm"><div>Surgical implantation of artificial lenses (due to high prevalence of infantile glaucoma)</div></li><li class="half_rhythm"><div>Contact lenses (due to risk for corneal keloids)</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Glaucoma</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manage w/standard medical &#x00026; surgical measures.</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Often difficult to control medically &#x00026; almost invariably requires surgery</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Developmental</b><br /><b>delays</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early infant therapy, preschool intervention program &#x00026; IEP throughout schooling</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Behavioral</b><br /><b>problems</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Behavior modification program</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Medication may also be needed for behavior control.</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anticonvulsant medication</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Renal tubular dysfunction</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oral supplements of sodium and potassium bicarbonate or citrate to correct acidosis &#x00026; hypokalemia</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Doses need to be titrated to individual needs based on "trough" blood concentrations of serum electrolytes (sodium, potassium, chloride, &#x00026; total carbon dioxide)</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Treatment w/oral phosphate, along w/oral calcitriol (1,25-dihydroxyvitamin D<sub>3</sub>) to correct hypophosphatemia &#x00026; renal rickets from renal tubular dysfunction</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Doses should also be titrated to individual needs based on trough blood concentration for phosphorus &#x00026; serum concentrations of 1,25-dihydroxyvitamin D, calcium, &#x00026; intact parathyroid hormone.</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">IV replacement of fluids, bicarbonate, &#x00026; electrolytes at times of illness associated w/vomiting &#x00026; diarrhea or when fasting (e.g. w/surgical procedures)</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ESRD</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chronic dialysis &#x00026; renal transplant may be successful in selected individuals.</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive renal tubular injury &#x02192; progressive glomerulosclerosis &#x00026; CKD &#x02192; ESRD (over yrs, usually by 2nd-4th decade)</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth/</b><br /><b>Feeding</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Growth hormone therapy &#x02192; improved growth velocity in some boys.</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Potential benefits of such therapy must be weighed against its costs/limitations.</td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">NG tube feedings or feeding gastrostomy w/or w/out fundoplication may be necessary to treat infant feeding &#x00026; nutrition problems related to hypotonia.</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Standard treatment for gastroesophageal reflux, if present</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis</b><br /><b>and joint</b><br /><b>hypermobility</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bracing or surgery may be performed to arrest or correct severe or progressive scoliosis &#x00026; joint hypermobility.</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Fibromas and</b><br /><b>cutaneous cysts</b></td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Resection may be needed if painful, recurrently infected, or limiting function.</td><td headers="hd_h_lowe.T.treatment_of_manifestations_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">CKD = chronic kidney diasease; ESRD = end-stage renal disease; IEP = individualized education program; NG = nasogastric</p></div></dd></dl></div></div></div></div><div id="lowe.Surveillance"><h3>Surveillance</h3><div id="lowe.T.recommended_surveillance_for_indi" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Lowe Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.T.recommended_surveillance_for_indi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.T.recommended_surveillance_for_indi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/<br />Concern</th><th id="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intraocular pressure monitoring</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6 mos life long</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Other ophthalmic evaluation</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>As determined by specialist based on type &#x00026; severity of eye abnormality</div></li><li class="half_rhythm"><div>Promptly w/any signs of &#x02191; intraocular pressure (e.g., excessive tearing, eye rubbing, change in clarity/transparency of cornea)</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>CNS</b></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental progress assessed &#x00026; educational plan updated</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2x/yr for 1st 3 yrs, then annually</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Brain imaging for any regression in abilities</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Kidneys</b></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kidney function assessment&#x000a0;<sup>1</sup></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At least yearly</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>If on supplemental bicarbonate or citrate, phosphorus or calcitriol or other vitamin D analog, need kidney function assessment&#x000a0;<sup>1</sup> w/blood &#x00026; urine tests</div></li><li class="half_rhythm"><div>May need serum vitamin D-25 hydroxy to assess for parent vitamin D deficiency</div></li></ul>
</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 3-6 mos; more often after dose changes</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Radiographs of long bones &#x00026; growth plates if renal bone disease is present</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular intervals as needed, but no more than every 6 mos</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Height/length &#x00026; weight</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Every 1-2 mos in infants</div></li><li class="half_rhythm"><div>Every 3-6 mos in older children &#x00026; adolescents</div></li><li class="half_rhythm"><div>Every 3 mos if on growth hormone</div></li></ul>
</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor scoliosis &#x00026; joint hypermobility</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examinations by a pediatric dentist</td><td headers="hd_h_lowe.T.recommended_surveillance_for_indi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2x/yr</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lowe.TF.5.1"><p class="no_margin">Testing includes measurement of (a) serum concentrations of electrolyte, blood urea nitrogen (BUN), creatinine, calcium, phosphorus, albumin, intact parathyroid hormone, and 1,25-dihydroxyvitamin D and (b) urinalysis and random urine protein, calcium, and creatinine.</p></div></dd></dl></div></div></div></div><div id="lowe.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p><b>Corneal contact lenses.</b> Because of the associated risks of corneal keloid formation and the inherent difficulties that the person with Lowe syndrome has in managing personal contact lens care, conventional eye glasses seem safer than corneal contact lenses.</p><p><b>Artificial lens implants.</b> Although some infants have had primary intraocular lens implantation at the time of cataract surgery, the associated risk of glaucoma appears higher in those infants with artificial lens implants. Therefore, artificial lens implants should be used with extreme caution, with intraocular pressure carefully monitored (under anesthesia if required) on a continual basis.</p></div><div id="lowe.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#lowe.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="lowe.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="lowe.Genetic_Counseling"><h2 id="_lowe_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="lowe.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Lowe syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="lowe.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder, nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>ORCL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div class="half_rhythm">In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>.</div><div class="half_rhythm">Note: If a woman has more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child and no other affected relatives and if the <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. In one study group, two (4.5%) of 44 women were found to have germline mosaicism [<a class="bk_pop" href="#lowe.REF.satre.1999.68">Satre et al 1999</a>, <a class="bk_pop" href="#lowe.REF.monnier.2000.157">Monnier et al 2000</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> or have <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a heterozygote. <i>De novo</i> pathogenic variants have been reported in approximately 32% of males with Lowe syndrome [<a class="bk_pop" href="#lowe.REF.satre.1999.68">Satre et al 1999</a>, <a class="bk_pop" href="#lowe.REF.monnier.2000.157">Monnier et al 2000</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">The mother of a child with Lowe syndrome who represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) should be thoroughly evaluated by an experienced ophthalmologist for the characteristic punctate anterior radial lens opacities seen in female heterozygotes.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the variant will be heterozygotes and will usually develop characteristic findings in the lens of each eye (see Clinical Description, <a href="#lowe.Females">Females</a>).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is still increased due to the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> which has been reported in five families with Lowe syndrome [<a class="bk_pop" href="#lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp &#x00026; Ludwig 2016</a>].</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males are not known to reproduce.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and the aunt's offspring, depending on their gender, may be at risk of being heterozygous or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Note: Molecular genetic testing may be able to identify the family member in whom a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> arose, information that could help determine genetic risk status of the extended family.</p></div><div id="lowe.Heterozygote_Detection"><h3>Heterozygote Detection</h3><p><b>Molecular genetic testing</b> of at-risk female relatives to determine their genetic status is most informative if the <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p><b>Slit lamp examination.</b> Approximately 95% of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females older than age 15 years are observed to have characteristic findings in the lens of the eye on slit lamp examination by an experienced ophthalmologist using both direct and retroillumination; thus, ophthalmologic exam may be used as a method of <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> detection.</p><p>Biochemical enzymatic assays for inositol polyphosphate 5-phosphatase OCRL-1 activity are <b>not</b> accurate for <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> detection because of lyonization (random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>) in females [<a class="bk_pop" href="#lowe.REF.lin.1999.119">Lin et al 1999</a>].</p></div><div id="lowe.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adult females who are heterozygotes, or are at risk of being heterozygotes.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="lowe.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>OCRL</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, molecular genetic prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Because of the relatively high rate (4.5%) of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, <b>every</b> mother of a male with Lowe syndrome, even with a negative family history, should be offered prenatal DNA testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in her son is known, even if the results of dilated slit lamp examination or DNA testing suggest that she is not a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> [<a class="bk_pop" href="#lowe.REF.mcspadden.2000">McSpadden 2000</a>].</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="lowe.Resources"><h2 id="_lowe_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Lowe Syndrome Association</b></div><div>PO Box 864346</div><div>Plano TX 75086-4346</div><div><b>Phone:</b> 972-733-1338</div><div><b>Email:</b> info@lowesyndrome.org</div><div><a href="http://www.lowesyndrome.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lowesyndrome.org</a></div></li><li class="half_rhythm"><div><b>Lowe Syndrome Trust</b></div><div>77 West Heath Road</div><div>London NW3 7TH</div><div>United Kingdom</div><div><b>Phone:</b> +44 0 20 7794 8858; +44 0 20 8458 6791</div><div><b>Email:</b> lst@lowetrust.com</div><div><a href="http://www.lowetrust.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lowetrust.com</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li><li class="half_rhythm"><div><b>eyeGENE - National Ophthalmic Disease Genotyping Network Registry</b></div><div><b>Phone:</b> 301-435-3032</div><div><b>Email:</b> eyeGENEinfo@nei.nih.gov</div><div><a href="https://eyegene.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nei.nih.gov/eyegene</a></div></li></ul></div><div id="lowe.Molecular_Genetics"><h2 id="_lowe_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="lowe.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Lowe Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_lowe.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_lowe.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_lowe.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_lowe.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_lowe.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_lowe.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_lowe.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4952" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>OCRL</i></a></td><td headers="hd_b_lowe.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4952" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq26<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_lowe.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q01968" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Inositol polyphosphate 5-phosphatase OCRL</a></td><td headers="hd_b_lowe.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=OCRL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OCRL @ LOVD at NCBI</a></td><td headers="hd_b_lowe.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=OCRL" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OCRL</a></td><td headers="hd_b_lowe.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=OCRL[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OCRL</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="lowe.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="lowe.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Lowe Syndrome (<a href="/omim/300535,309000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1480/table/lowe.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lowe.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300535" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300535</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">OCRL GENE; OCRL</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/309000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">309000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOWE OCULOCEREBRORENAL SYNDROME; OCRL</td></tr></tbody></table></div></div><div id="lowe.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Lowe syndrome results from loss of inositol polyphosphate 5-phosphatase OCRL-1 (phosphatidylinositol polyphosphate 5-phosphatase OCRL-1) activity. Although the exact mechanisms are unclear, the absence of the protein and elevated PtdIns (4,5) P<sub>2</sub> levels may affect these processes, which may influence all &#x02013; or a combination of some &#x02013; of the following:</p><ul><li class="half_rhythm"><div>Cell membrane composition</div></li><li class="half_rhythm"><div>Actin cytoskeletal organization</div></li><li class="half_rhythm"><div>Endocytosis</div></li><li class="half_rhythm"><div>Lysosomal-autophagic pathway</div></li><li class="half_rhythm"><div>Primary ciliary synthesis and function</div></li></ul><p>Loss of OCRL-1 ultimately leads to abnormal differentiation, cell migration, and function in certain cell types (i.e., renal tubule or lens epithelium). Such changes could result in the birth defects and other clinical manifestations of Lowe syndrome [<a class="bk_pop" href="#lowe.REF.zhang.1995.4853">Zhang et al 1995</a>, <a class="bk_pop" href="#lowe.REF.suchy.2002.1420">Suchy &#x00026; Nussbaum 2002</a>, <a class="bk_pop" href="#lowe.REF.ungewickell.2004.13501">Ungewickell et al 2004</a>, <a class="bk_pop" href="#lowe.REF.de_matteis.2017.455">De Matteis et al 2017</a>].</p><p>The enzyme is present in the trans-Golgi network and the endosomal and lysosomal compartment of a variety of cell types, including brain, skeletal muscle, heart, kidney (cultured proximal renal tubular cells), lung, ovary, testis, cultured fibroblasts, placenta, chorionic villi samples, and cultured amniocytes.</p><p><b>Mechanism of disease causation.</b> Lowe syndrome occurs through a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> mechanism. Reduced activity or absence of inositol polyphosphate 5-phosphatase OCRL-1 leads to elevated intracellular levels of its substrate, phosphatidylinositol (4,5) bisphosphate [PtdIns (4,5) P<sub>2</sub>] [<a class="bk_pop" href="#lowe.REF.zhang.1998.1574">Zhang et al 1998</a>], resulting in highly pleiotropic effects on a number of cellular processes. These processes include a defect in intracellular protein trafficking [<a class="bk_pop" href="#lowe.REF.vicinanza.2011.4970">Vicinanza et al 2011</a>], impaired endocytic tubular transport [<a class="bk_pop" href="#lowe.REF.festa.2018">Festa et al 2018</a>] and primary ciliary function [<a class="bk_pop" href="#lowe.REF.luo.2013.e66727">Luo et al 2013</a>]. Impaired endocytosis is most closely implicated in the low molecular-weight proteinuria and other tubular defects, while ciliary function abnormalities are more closely implicated in the ophthalmologic complications.</p><p>Of the identified pathogenic variants, 93% have been located in exons 10-18 and exons 19-23 of <i>OCRL</i>, particularly in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 15 [<a class="bk_pop" href="#lowe.REF.satre.1999.68">Satre et al 1999</a>, <a class="bk_pop" href="#lowe.REF.monnier.2000.157">Monnier et al 2000</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001">Nussbaum 2001</a>, <a class="bk_pop" href="#lowe.REF.nussbaum.2001_1">Nussbaum &#x00026; Suchy 2001</a>]. Recent data suggest an association between pathogenic variants in the first eight exons of <i>OCRL</i> and Dent disease [<a class="bk_pop" href="#lowe.REF.shrimpton.2009.27">Shrimpton et al 2009</a>, <a class="bk_pop" href="#lowe.REF.hichri.2011.379">Hichri et al 2011</a>]; however, the correlation is not perfect [<a class="bk_pop" href="#lowe.REF.tosetto.2009.1967">Tosetto et al 2009</a>].</p></div></div><div id="lowe.References"><h2 id="_lowe_References_">References</h2><div id="lowe.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.anglani.2018.187">Anglani F, Terrin L, Brugnara M, Battista M, Cantaluppi V, Ceol M, Bertoldi L, Valle G, Joy MP, Pober BR, Longoni M. Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai-Barrow syndrome. <span><span class="ref-journal">Clin Genet. </span>2018;<span class="ref-vol">94</span>:187–8.</span> [<a href="/pmc/articles/PMC5995642/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5995642</span></a>] [<a href="/pubmed/29532936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29532936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.athreya.1983.728">Athreya BH, Schumacher HR, Getz HD, Norman ME, Borden S 4th, Witzleben CL. Arthropathy of Lowe's (oculocerebrorenal) syndrome. <span><span class="ref-journal">Arthritis Rheum. </span>1983;<span class="ref-vol">26</span>:728–35.</span> [<a href="/pubmed/6860374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6860374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.bockenhauer.2008.1430">Bockenhauer D, B&#x000f6;kenkamp A, van't Hoff W, Levtchenko E, Kist-van Holthe JE, Tasic V, Ludwig M. Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2008;<span class="ref-vol">3</span>:1430–6.</span> [<a href="/pmc/articles/PMC2518783/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2518783</span></a>] [<a href="/pubmed/18480301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18480301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.b_kenkamp.2009.94">B&#x000f6;kenkamp A, B&#x000f6;ckenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M. Dent-2 disease: a mild variant of Lowe syndrome. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">155</span>:94–9.</span> [<a href="/pubmed/19559295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19559295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.b_kenkamp.2016.2201">B&#x000f6;kenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update. <span><span class="ref-journal">Pediatr Nephrol. </span>2016;<span class="ref-vol">31</span>:2201–12.</span> [<a href="/pmc/articles/PMC5118406/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5118406</span></a>] [<a href="/pubmed/27011217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27011217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.cau.2006.1030">Cau M, Addis M, Congiu R, Meloni C, Cao A, Santaniello S, Loi M, Emma F, Zuffardi O, Ciccone R, Sole G, Melis MA. A locus for familial skewed X chromosome inactivation maps to chromosome Xq25 in a family with a female manifesting Lowe syndrome. <span><span class="ref-journal">J Hum Genet. </span>2006;<span class="ref-vol">51</span>:1030–6.</span> [<a href="/pubmed/16955230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16955230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.charnas.1991.75">Charnas LR, Gahl WA. The oculocerebrorenal syndrome of Lowe. <span><span class="ref-journal">Adv Pediatr. </span>1991;<span class="ref-vol">38</span>:75–107.</span> [<a href="/pubmed/1927708" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1927708</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.charnas.1991.1318">Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA. Clinical and laboratory findings in the oculocerebrorenal syndrome of Low, with special reference to growth and renal function. <span><span class="ref-journal">N Engl J Med. </span>1991;<span class="ref-vol">324</span>:1318–25.</span> [<a href="/pubmed/2017228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2017228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.cibis.1982.1795">Cibis GW, Tripathi RC, Tripathi BJ, Harris DJ. Corneal keloid in Lowe's syndrome. <span><span class="ref-journal">Arch Ophthalmol. </span>1982;<span class="ref-vol">100</span>:1795–9.</span> [<a href="/pubmed/7138348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7138348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.cui.2010.f335">Cui S, Guerriero CJ, Szalinski CM, Kinlough CL, Hughey RP, Weisz OA. OCRL1 function in renal epithelial membrane traffic. <span><span class="ref-journal">Am J Physiol Renal Physiol. </span>2010;<span class="ref-vol">298</span>:F335–45.</span> [<a href="/pmc/articles/PMC2822509/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2822509</span></a>] [<a href="/pubmed/19940034" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19940034</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.de_matteis.2017.455">De Matteis MA, Staiano L, Emma F, Devuyst O. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. <span><span class="ref-journal">Nature Reviews Nephrology. </span>2017;<span class="ref-vol">13</span>:455–70.</span> [<a href="/pubmed/28669993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28669993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.elliman.1983.1011">Elliman D, Woodley A. Tenosynovitis in Lowe syndrome. <span><span class="ref-journal">J Pediatr. </span>1983;<span class="ref-vol">103</span>:1011.</span> [<a href="/pubmed/6644416" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6644416</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.festa.2018">Festa BP, Berquez M, Gassama A, Amrein I, Ismail HM, Samardzija M, Staiano L, Luciani A, Grimm C, Nussbaum RL, De Matteis MA, Dorchies OM, Scapozza L, Wolfer DP, Devuyst O. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and dent disease. <span><span class="ref-journal">Hum Mol Genet. </span>2018.</span> Epub ahead of print. [<a href="/pmc/articles/PMC6548226/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6548226</span></a>] [<a href="/pubmed/30590522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30590522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.finsterer.2017.487">Finsterer J, Scorza FA. Renal manifestations of primary mitochondrial disorders. <span><span class="ref-journal">Biomed Rep. </span>2017;<span class="ref-vol">6</span>:487–94.</span> [<a href="/pmc/articles/PMC5431253/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5431253</span></a>] [<a href="/pubmed/28515908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28515908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.harrison.1999.425">Harrison M, Odell EW, Sheehy EC. Dental findings in Lowe syndrome. . <span><span class="ref-journal">Pediatr Dent. </span>1999;<span class="ref-vol">21</span>:425–8.</span> [<a href="/pubmed/10633515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10633515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.hichri.2011.379">Hichri H, Rendu J, Monnier N, Coutton C, Dorseuil O, Poussou RV, Baujat G, Blanchard A, Nobili F, Ranchin B, Remesy M, Salomon R, Satre V, Lunardi J. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. <span><span class="ref-journal">Hum Mutat. </span>2011;<span class="ref-vol">32</span>:379–88.</span> [<a href="/pubmed/21031565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21031565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.hodgson.1986.837">Hodgson SV, Heckmatt JZ, Hughes E, Crolla JA, Dubowitz V, Bobrow M. A balanced de novo X/autosome translocation in a girl with manifestations of Lowe syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1986;<span class="ref-vol">23</span>:837–47.</span> [<a href="/pubmed/3953680" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3953680</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.hoopes.2005.260">Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ. Dent Disease with mutations in OCRL1. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">76</span>:260–7.</span> [<a href="/pmc/articles/PMC1196371/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1196371</span></a>] [<a href="/pubmed/15627218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15627218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.ikehara.2017.105">Ikehara S, Utani A. Multiple protrusive epidermal cysts on the scalp of a Lowe syndrome patient. <span><span class="ref-journal">J Dermatol. </span>2017;<span class="ref-vol">44</span>:105–7.</span> [<a href="/pubmed/27178641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27178641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.kenworthy.1993.297">Kenworthy L, Park T, Charnas LR. Cognitive and behavioral profile of the oculocerebrorenal syndrome of Lowe. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">46</span>:297–303.</span> [<a href="/pubmed/8488875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8488875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.kim.2014.140">Kim HK, Kim JH, Kim YM, Kim G-H, Lee BH, Choi J-H. Lowe syndrome: a single center&#x02019;s experience in Korea. <span><span class="ref-journal">Korean J Pediatr. </span>2014;<span class="ref-vol">57</span>:140–8.</span> [<a href="/pmc/articles/PMC4000760/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4000760</span></a>] [<a href="/pubmed/24778696" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24778696</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.lasne.2010.685">Lasne D, Baujat G, Mirault T, Lunardi J, Grelac F, Egot M, Salomon R, Bachelot-Loza C. Bleeding disorders in Lowe syndrome patients: evidence for a link between OCRL mutations and primary haemostasis disorders. <span><span class="ref-journal">Br J Haematol. </span>2010;<span class="ref-vol">150</span>:685–8.</span> [<a href="/pubmed/20629659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20629659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.laube.2004.479">Laube GF, Russell-Eggitt IM, van't Hoff WG. Early proximal tubular dysfunction in Lowe's syndrome. <span><span class="ref-journal">Arch Dis Child. </span>2004;<span class="ref-vol">89</span>:479–80.</span> [<a href="/pmc/articles/PMC1719890/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1719890</span></a>] [<a href="/pubmed/15102646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15102646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.leahey.1993.461">Leahey AM, Charnas LR, Nussbaum RL. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. <span><span class="ref-journal">Hum Mol Genet. </span>1993;<span class="ref-vol">2</span>:461–3.</span> [<a href="/pubmed/8504307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8504307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.lin.1999.119">Lin T, Lewis RA, Nussbaum RL. Molecular confirmation of carriers for Lowe syndrome. <span><span class="ref-journal">Ophthalmology. </span>1999;<span class="ref-vol">106</span>:119–22.</span> [<a href="/pubmed/9917791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9917791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.luo.2013.e66727">Luo N, Kumar A, Conwell M, Weinreb RN, Anderson R, Sun Y. Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e66727.</span> [<a href="/pmc/articles/PMC3689662/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3689662</span></a>] [<a href="/pubmed/23805271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23805271</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.mcspadden.2000">McSpadden K. <em>Living with Lowe Syndrome: A Guide for Families, Friends and Professionals.</em> 3 ed. Lowe Syndrome Association, Inc. 2000.</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.monnier.2000.157">Monnier N, Satre V, Lerouge E, Berthoin F, Lunardi J. OCRL1 mutation analysis in French Lowe syndrome patients: implications for molecular diagnosis strategy and genetic counseling. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">16</span>:157–65.</span> [<a href="/pubmed/10923037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10923037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.mueller.1991.804">Mueller OT, Hartsfield JK Jr, Gallardo LA, Essig YP, Miller KL, Papenhausen PR, Tedesco TA. Lowe oculocerebrorenal syndrome in a female with a balanced X;20 translocation: mapping of the X chromosome breakpoint. <span><span class="ref-journal">Am J Hum Genet. </span>1991;<span class="ref-vol">49</span>:804–10.</span> [<a href="/pmc/articles/PMC1683175/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1683175</span></a>] [<a href="/pubmed/1897526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1897526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.murakami.2018.372">Murakami Y, Wataya-Kaneda M, Iwatani Y, Kubota T, Nakano H, Katayama I. Novel mutation of <em>OCRL1</em> in Lowe syndrome with multiple epidermal cysts. <span><span class="ref-journal">J Dermatol. </span>2018;<span class="ref-vol">45</span>:372–3.</span> [<a href="/pubmed/28516463" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28516463</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.nussbaum.2001">Nussbaum RL. Lowe Syndrome <em>OCRL1</em> Mutation Database. Available <a href="http://research.nhgri.nih.gov/lowe/ocrl1_mut_db.shtml" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2001. Accessed 4-10-19.</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.nussbaum.2001_1">Nussbaum RL, Suchy SF. The oculocerebrorenal syndrome of Lowe (Lowe syndrome). In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. Chap 252. New York, NY: McGraw-Hill; 2001:6257-66.</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.recker.2015.931">Recker F, Zaniew M, Bockenhauer D, Miglietti N, B&#x000f6;kenkamp A, Moczulska A, Rogowska-Kalisz A, Laube G, Said-Conti V, Kasap-Demir B, Niemirska A, Litwin M, Siten G, Chrzanowska KH, Krajewska-Walasek A, Szczepanska M, Pawlaczyk K, Sikora P, Ludwig M. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. <span><span class="ref-journal">Pediatr Nephrol. </span>2015;<span class="ref-vol">30</span>:931–43.</span> [<a href="/pubmed/25480730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25480730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.reilly.1988.748">Reilly DS, Lewis RA, Ledbetter DH, Nussbaum RL. Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment. <span><span class="ref-journal">Am J Hum Genet. </span>1988;<span class="ref-vol">42</span>:748–55.</span> [<a href="/pmc/articles/PMC1715172/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715172</span></a>] [<a href="/pubmed/2895982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2895982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.r_schinger.2000.213">R&#x000f6;schinger W, Muntau AC, Rudolph G, Roscher AA, Kammerer S. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination. <span><span class="ref-journal">Mol Genet Metab. </span>2000;<span class="ref-vol">69</span>:213–22.</span> [<a href="/pubmed/10767176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10767176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.satre.1999.68">Satre V, Monnier N, Berthoin F, Ayuso C, Joannard A, Jouk PS, Lopez-Pajares I, Megabarne A, Philippe HJ, Plauchu H, Torres ML, Lunardi J. Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:68–76.</span> [<a href="/pmc/articles/PMC1378076/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1378076</span></a>] [<a href="/pubmed/10364518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10364518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.shrimpton.2009.27">Shrimpton AE, Hoopes RR Jr, Knohl SJ, Hueber P, Reed AA, Christie PT, Igarashi T, Lee P, Lehman A, White C, Milford DV, Sanchez MR, Unwin R, Wrong OM, Thakker RV, Scheinman SJ. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. <span><span class="ref-journal">Nephron Physiol. </span>2009;<span class="ref-vol">112</span>:27–36.</span> [<a href="/pubmed/19390221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19390221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.suchy.2002.1420">Suchy SF, Nussbaum RL. The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:1420–7.</span> [<a href="/pmc/articles/PMC378584/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378584</span></a>] [<a href="/pubmed/12428211" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12428211</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.tosetto.2009.1967">Tosetto E, Addis M, Caridi G, Meloni C, Emma F, Vergine G, Stringini G, Papalia T, Barbano G, Ghiggeri GM, Ruggeri L, Miglietti N, D'Angelo A, Melis MA, Anglani F. Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations. <span><span class="ref-journal">Pediatr Nephrol. </span>2009;<span class="ref-vol">24</span>:1967–73.</span> [<a href="/pubmed/19582483" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19582483</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.ungewickell.2004.13501">Ungewickell A, Ward ME, Ungewickell E, Majerus PW. The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:13501–6.</span> [<a href="/pmc/articles/PMC518786/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC518786</span></a>] [<a href="/pubmed/15353600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15353600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.vicinanza.2011.4970">Vicinanza M, Di Campli A, Polishchuk E, Santoro M, Di Tullio G, Godi A, Levtchenko E, De Leo MG, Polishchuk R, Sandoval L, Marzolo MP, De Matteis MA. OCRL controls trafficking through early endosomes via PtdIns4,5P<sub>2</sub>-dependent regulation of endosomal actin. <span><span class="ref-journal">EMBO J. </span>2011;<span class="ref-vol">30</span>:4970–85.</span> [<a href="/pmc/articles/PMC3242071/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3242071</span></a>] [<a href="/pubmed/21971085" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21971085</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.warner.2017.2017">Warner BE, Inward CD, Burren CP. Gonadotrophin abnormalities in an infant with Lowe syndrome. <span><span class="ref-journal">Endocrinol Diabetes Metab Case Rep. </span>2017 Apr 19;:2017.</span> [<a href="/pmc/articles/PMC5409933/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5409933</span></a>] [<a href="/pubmed/28469921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28469921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.zaniew.2018.85">Zaniew M, B&#x000f6;kenkamp A, Kolbuc M, La Scola C, Baronio F, Niemirska A, Szczepanska M, Burger J, La Manna A, Miklaszewska M, Rogowsha-Kalisz A, Gellermann J, Zampetoglou A, Wasilewska A, Roszak M, Moczko J, Krzemien A, Runowski D, Siten G, Zaluska-Lesniewska I, Fonduli P, Zurrida F, Paglialonga F, Gucev Z, Paripovic D, Rus R, Said-Conti V, Sartz L, Chung WY, Park SJ, Lee JW, Park YH, Ahn YH, Sikora P, Stefanidis CJ, Tasic V, Konrad M, Anglani F, Addis M, Cheong HI, Ludwig M, Bockehauer D. Long-term renal outcome in children with <em>OCRL</em> mutations: retrospective analysis of a large international cohort. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2018;<span class="ref-vol">33</span>:85–94.</span> [<a href="/pubmed/27708066" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27708066</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.zhang.1998.1574">Zhang X, Hartz PA, Philip E, Racusen LC, Majerus PW. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:1574–82.</span> [<a href="/pubmed/9430698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9430698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lowe.REF.zhang.1995.4853">Zhang X, Jefferson AB, Auethavekiat V, Majerus PW. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5- bisphosphate 5-phosphatase. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1995;<span class="ref-vol">92</span>:4853–6.</span> [<a href="/pmc/articles/PMC41805/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC41805</span></a>] [<a href="/pubmed/7761412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7761412</span></a>]</div></li></ul></div></div><div id="lowe.Chapter_Notes"><h2 id="_lowe_Chapter_Notes_">Chapter Notes</h2><div id="lowe.Author_History"><h3>Author History</h3><p>Eileen D Brewer, MD (2007-present) <br />Richard A Lewis, MD, MS (2007-present) <br />Robert L Nussbaum, MD (2007-present) <br />Rebecca S Wappner, MD, FAAP, FACMG; Indiana University School of Medicine (2001-2007)</p></div><div id="lowe.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 April 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 February 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 March 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis available on a clinical basis</div></li><li class="half_rhythm"><div>16 November 2007 (cd) Revision: mutation scanning no longer available on a clinical basis</div></li><li class="half_rhythm"><div>5 January 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 September 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 July 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>13 April 2001 (rw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1480</span><span class="label">PMID: <a href="/pubmed/20301653" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301653</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rws/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lds/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1480&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1480/?report=reader">PubReader</a></li><li><a href="/books/NBK1480/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1480" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1480" style="display:none" title="Cite this Page"><div class="bk_tt">Lewis RA, Nussbaum RL, Brewer ED. Lowe Syndrome. 2001 Jul 24 [Updated 2019 Apr 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1480/pdf/Bookshelf_NBK1480.pdf">PDF version of this page</a> (499K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#lowe.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#lowe.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#lowe.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#lowe.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#lowe.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#lowe.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#lowe.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#lowe.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#lowe.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#lowe.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#lowe.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4952[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">OCRL</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1500188" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1500188" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1500188" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1500188" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22876375" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dent Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dent Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Cogal A, Abrash E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301534" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PAX6</i>-Related Aniridia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moosajee M, Hingorani M, Moore AT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301574" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cystinosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cystinosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nesterova G, Gahl WA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27011217" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The oculocerebrorenal syndrome of Lowe: an update.</a><span class="source">[Pediatr Nephrol. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> The oculocerebrorenal syndrome of Lowe: an update.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bökenkamp A, Ludwig M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Nephrol. 2016 Dec; 31(12):2201-2212. Epub 2016 Mar 24.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301653" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301653" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0413dcdd21425a25cd72b1">Lowe Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Lowe Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:58:52-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AF2D1E040FC010000000001BC00AD&amp;ncbi_session=CE8AF2D1E0413DC1_0444SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1480%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1480&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1480/&amp;ncbi_pagename=Lowe Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AF2D1E0413DC1_0444SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>